Listen
Reason for request
Renouvellement d'inscription
-
Clinical Benefit
| Moderate |
The actual benefit of UMATROPE in adults with GH deficiency remains moderate. The actual benefit provided by UMATROPE in children with SHOX gene deficiency remains moderate. |
| Substantial |
The actual benefit of UMATROPE in children with GH deficiency remains substantial . |
| Low |
The actual benefit of UMATROPE in children born small for gestational age with a birth weight and/or height < -2 SD, who have failed to show catch-up growth (growth velocity < 0 SD during the last year) by 4 years of age or later and whose growth retardation (current height) is below or equal to -3 SD and the adjusted parental height < -1 SD remains low. . |
English version
Contact Us
Évaluation des médicaments
